NCT00254540 - Study of SU011248 in Patients With Advanced Kidney Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Carcinoma, Renal Cell

Interventions

DRUG

SU011248 capsule

50mg, PO on day 28 of each 42 day cycle, until progression or unacceptable toxicity develops

Trial Locations (11)

Pfizer Investigational Site, Akita

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Tsukuba

Pfizer Investigational Site, Osaka

Pfizer Investigational Site, Sayama

Pfizer Investigational Site, Hamamatsu

Pfizer Investigational Site, Sunto-gun

Pfizer Investigational Site, Tokushima

Pfizer Investigational Site, Chuo-ku

Pfizer Investigational Site, Yamagata

Pfizer Investigational Site, Fukuoka